Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Condition(s):HIV InfectionsLast Updated:November 1, 2021Completed
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:November 1, 2021Completed
Condition(s):Infection, Human Immunodeficiency Virus; HIV InfectionsLast Updated:February 4, 2019Completed
Condition(s):Infections, Human Immunodeficiency Virus and HerpesviridaeLast Updated:September 19, 2011Completed
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:April 30, 2012Completed
Condition(s):HIV InfectionLast Updated:August 31, 2017Completed
Condition(s):Healthy Subjects; Hepatic Impairment; Infection, Human Immunodeficiency Virus; HIV InfectionsLast Updated:July 31, 2019Completed
Condition(s):HIV InfectionsLast Updated:September 20, 2012Completed
Condition(s):HIV-1-infection; TuberculosisLast Updated:October 23, 2017Unknown status
Condition(s):Monotherapy; Dolutegravir; Primary HIV Infection; Treatment EfficacyLast Updated:October 12, 2018Unknown status
Condition(s):Infections, Human Immunodeficiency Virus and HepatitisLast Updated:April 9, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.